1. Catalogs
  2. Jiangsu Mole Bioscience
  3. HPV Catalogue_S02104T2096

HPV Catalogue_S02104T2096

HPV Catalogue_S02104T2096

HPV Catalogue_S02104T2096

Product catalog summary
Testing Principle
Multiple fluorescent PCR is utilized to simultaneously identify HPV types 16, 18, and other types (26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82).
Purpose of HPV Testing
HPV testing is crucial as cervical cancer is a leading cause of mortality among women. In 2020, approximately 604,000 women were diagnosed with cervical cancer globally, with about 342,000 deaths. WHO guidelines recommend HPV screening every 5 to 10 years for women aged 30 and above.
Product Features
  • Minimizes PCR contamination using the UNG/dUTP system.
  • Simultaneously distinguishes the two most common HPV types and 16 other middle-high risk infections.
  • Fast detection, completing tests within 2 hours.
  • High sensitivity with a limit of detection (Lod) of 500 copies/mL for HPV 16 and 18, and 1×103 copies/mL for other types.
Ordering Information
Available in liquid and lyophilized versions with varying test sizes (24, 48, 64, 96 tests per kit). Storage conditions are specified as -20±5°C and 2-8°C.
Applicable Instruments
Compatible with Applied Biosystems 7500 Real-Time PCR System, BioRad CFX96 Real-Time PCR System, and other PCR instruments with FAM, ROX, VIC (HEX), and Cy5 channels.
Reliability
Includes an internal control in each tube to monitor the entire testing process and prevent false-negative results.
See more

Catalog excerpts

HPV Catalogue_S02104T2096-1

Human Papillomavirus Nucleic Acid Ampilification Test Kit (Fluorescent Probe-Based Real-Time PCR Assay) -Prediction Indicators for Cervical Cancer Why do we test HPV ? Cervical cancer is a leading cause of mortality among women. In 2020, an estimated 604,000 women were diagnosed with cervical cancer worldwide and about 342,000 women died from the disease. In the new WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, WHO suggests among the general population of women at the age of 30 years screening HP V every 5 to 10 years.

 Open the catalog to page 1
HPV Catalogue_S02104T2096-2

Products Features Wide Coverage Fast Detection High Sensitivity The 2 most common types and other 16 middle-high risk UNG/dUTP system. guished at the same time. Reliable Results Internal control included in each tube monitoring whole testing processes and avoid false-negative results. Applicable Instruments Example Result Amplification Plot Applied BiosystemsTM 7500 Real-Time PCR 2500, 000 BioRad CFX96 Real-Time PCR System Other PCR instruments with simultaneous detection of FAM, ROX, VIC (HEX) and Cy5 Contamination Control Sample Type Storage time 24 Tests/ Kit Human Papillomavirus Nucleic Acid...

 Open the catalog to page 2

Archived catalogs

  1. B052T050B0C2

    2  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.